CKPTCheckpoint Therapeutics, Inc.

Nasdaq checkpointtx.com


$ 1.56 $ -0.02 (-1.27 %)    

Friday, 03-May-2024 11:01:35 EDT
QQQ $ 433.32 $ 1.00 (0.23 %)
DIA $ 385.48 $ -1.26 (-0.33 %)
SPY $ 508.89 $ -1.64 (-0.32 %)
TLT $ 89.48 $ -0.63 (-0.7 %)
GLD $ 212.22 $ -1.20 (-0.56 %)
$ 1.48
$ 1.58
$ 1.56 x 100
$ 1.58 x 100
$ 1.56 - $ 1.58
$ 1.30 - $ 3.62
325,099
na
27.74M
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-22-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-11-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-16-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-17-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-checkpoint-therapeutics-maintains-34-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $...

 checkpoint-therapeutics-fy23-eps-317-vs-709-yoy-as-of-december-31-2023-checkpoints-cash-and-cash-equivalents-totaled-49m

Financial Results: Cash Position: As of December 31, 2023, Checkpoint's cash and cash equivalents totaled $4.9 million, ...

 pinterest-checkpoint-therapeutics-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

 b-riley-securities-maintains-buy-on-checkpoint-therapeutics-lowers-price-target-to-4-report-released-on-19th-december-2023

B. Riley Securities analyst Mayank Mamtani maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and lowers the price t...

 b-riley-securities-maintains-buy-on-checkpoint-therapeutics-lowers-price-target-to-4

B. Riley Securities analyst Mayank Mamtani maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and lowers the price t...

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

 hc-wainwright--co-reiterates-buy-on-checkpoint-therapeutics-maintains-34-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $...

 nasdaq-gains-100-points-biomerica-shares-spike-higher

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The D...

 why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

 crude-oil-rises-3-us-housing-market-index-increases-in-december

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded ...

 dow-gains-over-50-points-nippon-steel-to-acquire-u-s-steel

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market open...

 whats-going-on-with-checkpoint-therapeutics-ckpt-stock-nosediving

Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares are trading lower by 52.7% to $1.57 Monday morning after the company received...

 the-fda-has-issued-a-complete-response-letter-to-checkpoint-therapeutics-cosibelimab-biologic-license-application-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma-who-are-not-candidates-for-curative-surgery-or-radiation

The CRL only cites findings that arose during a multi-sponsor inspection of Checkpoint's third-party contract manufacturing...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION